An integrative approach of digital image analysis and transcriptome profiling to explore potential predictive biomarkers for TGF
Artificial intelligence
Digital pathology
Machine learning
Predictive biomarker
T cell infiltration
TGFβ
Transcriptomic profiling
Tumor topography
Journal
Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
14
12
2021
revised:
15
01
2022
accepted:
03
03
2022
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
1
10
2022
Statut:
ppublish
Résumé
Increasing evidence suggests that the presence and spatial localization and distribution pattern of tumor infiltrating lymphocytes (TILs) is associate with response to immunotherapies. Recent studies have identified TGF
Identifiants
pubmed: 36176910
doi: 10.1016/j.apsb.2022.03.013
pii: S2211-3835(22)00143-5
pmc: PMC9513441
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3594-3601Informations de copyright
© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
Références
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Elife. 2018 Sep 04;7:
pubmed: 30179157
Clin Cancer Res. 2016 Apr 15;22(8):1865-74
pubmed: 27084740
Nat Commun. 2021 Jan 11;12(1):227
pubmed: 33431814
Cancer Immunol Immunother. 2017 Jan;66(1):33-43
pubmed: 27770170
Melanoma Res. 2017 Jun;27(3):211-217
pubmed: 28118270
Mol Cancer. 2010 May 26;9:122
pubmed: 20504320
Am J Reprod Immunol. 2020 Jul;84(1):e13244
pubmed: 32294293
N Engl J Med. 2011 Dec 29;365(26):2484-96
pubmed: 22204725
Cancer Cell. 2003 Jun;3(6):537-49
pubmed: 12842083
Cell. 2008 Apr 4;133(1):66-77
pubmed: 18394990
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Onco Targets Ther. 2020 Jul 03;13:6475-6483
pubmed: 32753888
Front Physiol. 2020 Oct 19;11:583333
pubmed: 33192595
Oncotarget. 2019 Jan 25;10(8):810-824
pubmed: 30783512
Oncoimmunology. 2018 Nov 20;8(2):e1539613
pubmed: 30713798
Sci Rep. 2019 Mar 14;9(1):4551
pubmed: 30872619
Clin Cancer Res. 2020 Feb 15;26(4):870-881
pubmed: 31757879
Cancers (Basel). 2021 Feb 25;13(5):
pubmed: 33669038
Oncoimmunology. 2020 Sep 13;9(1):1811605
pubmed: 33224628
Sci Rep. 2021 Jan 19;11(1):1834
pubmed: 33469107
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
EClinicalMedicine. 2021 Sep 16;41:101134
pubmed: 34585125
Immunity. 2018 Apr 17;48(4):626-628
pubmed: 29669246
Clin Immunol. 2021 May;226:108707
pubmed: 33662590
Cancers (Basel). 2019 Sep 19;11(9):
pubmed: 31546872
J Natl Cancer Inst. 2005 Dec 21;97(24):1808-15
pubmed: 16368942
Histopathology. 2012 Jul;61(1):18-25
pubmed: 22372580
Mol Cancer. 2021 Jan 11;20(1):14
pubmed: 33430876
Cancer Treat Res. 2020;180:173-195
pubmed: 32215870
Cell Rep. 2018 Apr 3;23(1):181-193.e7
pubmed: 29617659
Lab Invest. 2007 Jul;87(7):662-9
pubmed: 17334408
Sci Rep. 2021 Feb 2;11(1):2809
pubmed: 33531581
Nat Med. 2002 Nov;8(11):1323-7
pubmed: 12389040
Trends Immunol. 2020 May;41(5):406-420
pubmed: 32223932
Nat Commun. 2020 Nov 4;11(1):5583
pubmed: 33149148